FindMyKOL
Clinical trialNCT01776307CompletedPhase 2Interventional

A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

SponsorSumitomo Pharma America, Inc.Enrollment200Colorectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an open label, multi-center, Phase 2 study of BBI608 in combination with cetuximab, panitumumab or capecitabine in patients with advanced colorectal cancer.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • William J. Edenfield, MD

    Institute for Translational Oncology Research, Greenville Hospital System

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic

    Scottsdale, Arizona, United States

  • Usor - Rocky Mountain Cancer Center

    Denver, Colorado, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Usor - Minnesota Oncology Hematology

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • the Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

  • Usor - Northwest Cancer Specialists

    Portland, Oregon, United States

  • Abramson Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Institute for Translational Oncology Research, Greenville Hospital System

    Greenville, South Carolina, United States

  • Usor - Texas Oncology Dallas

    Dallas, Texas, United States

  • Us Oncology Research

    The Woodlands, Texas, United States

  • Usor - Texas Oncology Tyler

    Tyler, Texas, United States

  • Usor - Virginia Cancer Specialists

    Fairfax, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2012
Primary completion
30 Jun 2018
Completion
30 Apr 2020
Last update posted
15 Nov 2023
Registered enrollment
200
Registry id
NCT01776307

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.